Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Positron-emission tomography (PET) imaging enhancement refers to a suite of techniques, technologies, and methodologies aimed at improving the quality, resolution, and diagnostic utility of PET scans. These enhancements can be achieved through hardware advancements (such as improved detectors), software-based image processing (including denoising and deblurring), artificial intelligence (AI)-driven algorithms, motion correction strategies, and the development of novel radiotracers. Enhancement techniques improve visualization of biological processes in vivo by increasing image clarity and quantitative accuracy, enabling more precise detection and characterization of disease states, particularly cancer. Key methods include noise reduction, spatial resolution improvement, AI-based image processing, digital detector technology, and motion correction. Enhanced PET imaging is crucial for early disease detection, monitoring therapeutic response, and reducing radiation exposure or scan time.
N/A - Enhancement techniques improve image quality but do not have a direct mechanism of action in the way a drug does.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Positron-Emission Tomography Imaging Enhancement (PET Imaging Enhancement).